Market Place
Sourcing Support
ImmunoBrain Checkpoint Appoints Dr. Sanjay Keswani as Chief Executive Officer
22 Jan 2024 //
PR NEWSWIRE
First subjects in IBC’s Phase Ib trial receive IBC-Ab002
18 May 2023 //
CLINICAL TRIALS ARENA
ImmunoBrain Checkpoint Doses First Patients in Phase 1b Trial of IBC-Ab002
17 May 2023 //
PR NEWSWIRE
ImmunoBrain Awarded $5M for Phase 1b Alzheimer’s Disease of Anti-PD-L1 IBC-Ab002
27 Aug 2021 //
GLOBENEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.